4623-74-9 Usage
Uses
Used in Pharmaceutical Industry:
Carvedilol is used as a therapeutic agent for the treatment of high blood pressure, congestive heart failure, and left ventricular dysfunction. Its application is based on its ability to block the action of natural substances like epinephrine on the heart and blood vessels, which helps to lower blood pressure, improve heart function, and reduce strain on the heart.
Used in Migraine Prevention:
In the field of neurology, carvedilol is used as a preventive measure for migraine headaches. Its application in this context is due to its potential to stabilize blood vessels and reduce the frequency and severity of migraines.
Used in Essential Tremor Treatment:
Carvedilol is also utilized as a treatment option for essential tremor, a neurological disorder characterized by involuntary shaking or trembling. Its application in this area is attributed to its ability to regulate the autonomic nervous system and provide relief from the symptoms of essential tremor.
Used in Cardiovascular Health:
Carvedilol is used as a cardiovascular agent to improve heart function and reduce the risk of heart-related complications. Its application in this industry is based on its capacity to lower blood pressure and reduce the strain on the heart, which in turn helps to prevent further damage and improve overall cardiovascular health.
Check Digit Verification of cas no
The CAS Registry Mumber 4623-74-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,2 and 3 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4623-74:
(6*4)+(5*6)+(4*2)+(3*3)+(2*7)+(1*4)=89
89 % 10 = 9
So 4623-74-9 is a valid CAS Registry Number.
4623-74-9Relevant articles and documents
Iridium-catalysed primary alcohol oxidation and hydrogen shuttling for the depolymerisation of lignin
Lancefield, Christopher S.,Teunissen, Lucas W.,Weckhuysen, Bert M.,Bruijnincx, Pieter C. A.
, p. 3214 - 3221 (2018/07/31)
Lignin is a potentially abundant renewable resource for the production of aromatic chemicals, however its selective depolymerisation is challenging. Here, we report a new catalytic system for the depolymerisation of lignin to novel, non-phenolic monoaromatic products based on the selective β-O-4 primary alcohol dehydrogenation with a Cp?Ir-bipyridonate catalyst complex under basic conditions. We show that this system is capable of promoting the depolymerisation of model compounds and isolated lignins via a sequence of selective primary alcohol dehydrogenation, retro-aldol (Cα-Cβ) bond cleavage and in situ stabilisation of the aldehyde products by transfer (de)hydrogenation to alcohols and carboxylic acids. This method was found to give good to excellent yields of cleavage products with both etherified and free-phenolic lignin model compounds and could be applied to real lignin to generate a range of novel non-phenolic monomers including diols and di-acids. We additionally show, by using the same catalyst in a convergent, one-pot procedure, that these products can be selectively channelled towards a single di-acid product, giving much simpler product mixtures as a result.
